Heart Failure Clinics

Papers
(The TQCC of Heart Failure Clinics is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Contributors43
Valvular Regurgitation in Adults with Congenital Heart Disease and Heart Failure33
The Pathophysiology(ies) of Heart Failure in Adults with Congenital Heart Disease24
Advanced Heart Failure: From Pathophysiology to Clinical Management22
Mitral and Tricuspid Valves Percutaneous Repair in Patients with Advanced Heart Failure21
Advanced Heart Failure in Special Population21
Modeling Susceptibility to Cardiotoxicity in Cancer Therapy Using Human iPSC-Derived Cardiac Cells and Systems Biology21
Novelties in Therapy of Chronic Heart Failure20
Tricuspid Regurgitation and Right Heart Failure20
The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis19
Heart Failure with Preserved Ejection Fraction18
Copyright18
Management of Advanced Heart Failure: The Science of Uncertainty and the Art of Probability18
Congestion in Patients with Advanced Heart Failure16
Cardiovascular Effects of COVID-1916
SGLT-2 Inhibitors16
Radiation-Induced Cardiac Dysfunction15
Training and Career Development in Cardio-Oncology Translational and Implementation Science15
Unusual Forms of Pulmonary Hypertension15
Contributors15
Aortic Valvular Stenosis and Heart Failure14
Struggling Between Liver Transplantation and Portopulmonary Hypertension14
Contents14
Electronic Health Records and Heart Failure13
Contributors13
The Risk of Sudden Death in Children with Hypertrophic Cardiomyopathy12
Invasive Hemodynamics in Heart Failure with Preserved Ejection Fraction11
Monitoring for Valve Decrepitude: Surveillance Echo for All at Age 60…?11
Sleep Disorder and Heart Failure with Preserved Ejection Fraction10
Targeted Therapies for Microvascular Disease10
Adults with Congenital Heart Disease and Transplant10
Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies10
Tafamidis in the Treatment of ATTR-related Cardiomyopathy10
Surgical Considerations in Adult Congenital Heart Disease Heart Failure10
Using Artificial Intelligence to Better Predict and Develop Biomarkers9
Anemia and Management of Heart Failure Patients9
Treatment of Advanced Heart Failure—Focus on Transplantation and Durable Mechanical Circulatory Support9
Cardiopulmonary Exercise Testing in Pulmonary Hypertension9
Challenges in Pulmonary Hypertension9
A Review of Heart Failure in Patients with COVID-198
Utilizing Artificial Intelligence to Enhance Health Equity Among Patients with Heart Failure8
Exercise-Based Cardiac Rehabilitation Programs in Heart Failure Patients8
Exercise Intolerance in Heart Failure with Preserved Ejection Fraction7
Immune Dysregulation in Ischemic Heart Disease Among Individuals with Human Immunodeficiency Virus7
Forthcoming Issues7
Racial, Ethnic, and Gender Disparities in Valvular Heart Failure Management7
Understanding Myocardial Metabolism in the Context of Cardio-Oncology7
Contributors6
Copyright6
Contents6
Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction6
Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia6
Therapy-Related Clonal Hematopoiesis6
Digital Health6
Renoprotective Effects of SGLT2 Inhibitors6
Changing Landscape of Heart Failure Imaging6
Forthcoming Issues6
Obesity in Heart Failure with Reduced Ejection Fraction6
Cardiovascular Involvement in mtDNA Disease5
Exercise Testing in Pulmonary Hypertension and Heart Failure5
Clinical Heart Failure Scenarios: From Prevention to Overt Disease and Rehabilitation5
Cardiovascular Magnetic Resonance in the Management of Cardiac Amyloidosis5
The Non-invasive Assessment of the Pulmonary Circulation-Right Ventricular Functional Unit5
Copyright5
The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis5
Comprehensive Assessment of Heart Failure with Preserved Ejection Fraction Using Cardiac MRI5
Contents5
Contents5
Noninvasive Assessment of Ventricular-Arterial Coupling in Heart Failure5
Genotype-Phenotype Correlations in ATTR Amyloidosis5
SGLT2 Inhibitors and Peripheral Vascular Events4
Epidemiology and Definition of Heart Failure in Adult Congenital Heart Disease4
Stage A Heart Failure4
Clinical Practice Guidelines in Cardio-Oncology4
Remote Monitoring Devices and Heart Failure4
Pathophysiology of Advanced Heart Failure4
Left Ventricular Assist Device4
Interventional Approaches to Augment Pharmacotherapy in Heart Failure4
Machine Learning in Cardiovascular Imaging4
Contents4
Cardiovascular Health Care Implications of the COVID-19 pandemic4
SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction4
Vision Statement and Call to Action for Adult Congenital Heart Disease Heart Failure4
Viral Myocarditis and Dilated Cardiomyopathy as a Consequence—Changing Insights from Advanced Imaging4
When all Else Fails, Try This4
0.12498784065247